Galen Kabulski, Pharm.D., BCCP

CVICU Pharm.D. 🫀 drugs and 🫀accessories.

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Come see us at ASHP Midyear and learn more about our PGY2 Cardiology Program at WVU Medicine!

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Interested in joining a cardiology team with the opportunity to cover cardiology patients across acute care and critical care services? @WVUMedicine is hiring a Clinical Pharmacy Specialist - Cardiology Float!

https://t.co/Bkas0jxLWv

[Journal of Cardiothoracic and Vascular Anesthesia @JCVAonline]

The Effect of Extracorporeal Membrane Oxygenation on the Pharmacokinetics of Dexmedetomidine Hydrochloride. #ECMO #dexmedetomidine
https://t.co/TfOhCqlH9k
Figure 4:

[ACCP Cardiology PRN @accpcardprn]

Paul Badua from WVU Medicine presented on "Effectiveness of Antiarrhythmic Drugs for the Prevention of Automated Implantable Cardiac Defibrillator Therapies"

[ACCP Cardiology PRN @accpcardprn]

Check out this wonderful #TeachingTuesday post by @WVUMedicine PGY2 Cardiology Resident Sara Hudson! The SWAP trials were paramount to our knowledge of managing P2Y12i. Does your institution follow the protocols used in the studies? 🤔🫀

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

WVU Medicine is participating in phase two of the match for our PGY2 Cardiology program. If interested, feel free to reach out for more information!

https://t.co/waNIU9jeXQ

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Awesome work by our PGY2 cardiology resident, Sara! ⬇️

[ACCP Cardiology PRN @accpcardprn]

This week's PGY2 CE Spotlight is brought to you by Dr. Sara Hudson from WVU! She discusses the role of induction therapy in heart transplantation!

[ACCP Cardiology PRN @accpcardprn]

This week's PGY2 CE Spotlight is brought to you by Dr. Sara Hudson from WVU! She discusses the role of induction therapy in heart transplantation!

[ACCP Cardiology PRN @accpcardprn]

It's been a few weeks, but we're back with another PGY2 CE spotlight!! @RockholdMatthew from WVU Medicine reviews postoperative AF, highlighting the pathophys, studied preventative measures, and treatment when POAF occurs!! #twitterx

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

A few PVCs never hurt anyone, right?

[ACCP Cardiology PRN @accpcardprn]

Its #teachingtuesday! Check out this infographic created by @RockholdMatthew on transcatheter mitral valve devices. What antithrombotic therapy is your institution using surrounding these devices? 🤔 🤔 🤔

[ACCP Cardiology PRN @accpcardprn]

Curious in learning more about transcatheter mitral valve devices? Learn from current PGY-2 Cardiology Resident, @RockholdMatthew, next week on #teachingtuesday! 🫀 🫀

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

How do you handle resuming HFrEF GDMT in patients following cardiac surgery? Still room to optimize in this often challenging population. Check out our experience at #WVU. Many thanks to collaborators @KazuhikoKido and @docsok99

https://t.co/HDM2ES3R3B

[Erika Zarfoss Ponce, PharmD, BCCCP @ErikaZ_PharmD]

Standard vs high dose dexmedetomidine for #ECMO: Just as safe, but no more effective

❤️ No difference in bradycardia (49vs38%)
📉 No difference in hypotension (79vs71%)
💊 No difference in pressors (75vs71%)
💉 No difference in added analgesia or prop

https://t.co/PT2tOja92M

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Do you enjoy helping mend sick 🫀?@WVUMedicine is hiring a cardiology pharmacy specialist float for our growing division - join our team!

https://t.co/2q2Z8LOzpq

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Successful day yesterday for @WVUHPharmRes - looking forward to welcoming our incoming class, including our inaugural PGY2 Cardiology resident @WVUMedicine. Congratulations to all who matched!

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

Looking for a PGY2 program in Cardiology? The mountains are calling! @WVUHPharmRes at @WVUMedicine is recruiting for the upcoming 2022 - 2023 academic year. Excited for someone to join our growing 🫀 team!

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

WVU Medicine will begin our new PGY2 Cardiology Residency beginning in 2022 - 2023 in thanks to a lot of hard work by a lot of folks. Excited to begin recruiting! #WVU

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

@ErikaZ_PharmD Subtweet

[Galen Kabulski, Pharm.D., BCCP @CTSPharmG]

@ansakhuja

[Journal of Cardiothoracic and Vascular Anesthesia @JCVAonline]

#AKI risk in adult Chinese cardiac surgery patients
•58399 patients
•34% any-stage AKI, 1.7% KDIGO stage-3 AKI
•0.69 AUC for any-stage AKI, 0.84 for stage-3
https://t.co/5S9PK3c3vY
#anesthesia #criticalcare #cardiac #kidney